A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients
Clinical trial NCT01440920 · COMPLETED
Trial details
- NCT number
- NCT01440920
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-03-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.